X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1821) 1821
Publication (98) 98
Patent (72) 72
Book Chapter (10) 10
Book Review (4) 4
Magazine Article (4) 4
Conference Proceeding (2) 2
Dissertation (2) 2
Newsletter (2) 2
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (727) 727
male (350) 350
female (341) 341
adult (293) 293
gastroenterology & hepatology (290) 290
middle aged (265) 265
animals (166) 166
virology (154) 154
infection (132) 132
aged (130) 130
index medicus (128) 128
microbiology (121) 121
infectious diseases (116) 116
antiviral agents - therapeutic use (102) 102
hepatitis c (92) 92
gastroenterology and hepatology (91) 91
hepatitis b virus (89) 89
molecular sequence data (84) 84
risk factors (81) 81
hepatitis b virus - genetics (80) 80
polymerase chain reaction (80) 80
hepacivirus - genetics (76) 76
genotype (74) 74
chemistry (72) 72
life sciences (72) 72
therapy (72) 72
hepatitis (71) 71
immunology (71) 71
treatment outcome (71) 71
adolescent (70) 70
metallurgy (70) 70
liver - pathology (68) 68
biochemistry (67) 67
hygiene (67) 67
interferon-alpha - therapeutic use (67) 67
human necessities (66) 66
medical or veterinary science (66) 66
preparations for medical, dental, or toilet purposes (66) 66
base sequence (65) 65
beer (65) 65
enzymology (65) 65
mutation or genetic engineering (65) 65
peptides (65) 65
spirits (65) 65
vinegar (65) 65
wine (65) 65
recombinant proteins (64) 64
chronic disease (63) 63
liver (63) 63
hepatitis c virus (62) 62
culture media (61) 61
hepatocellular carcinoma (61) 61
interferon (61) 61
drug therapy, combination (60) 60
compositions thereof (59) 59
microorganisms or enzymes (59) 59
organic chemistry (59) 59
propagating, preserving or maintaining microorganisms (59) 59
prospective studies (59) 59
prevalence (58) 58
cirrhosis (57) 57
replication (57) 57
hepatitis b (56) 56
hepatitis c, chronic - drug therapy (56) 56
hepatitis b virus - immunology (53) 53
dna (51) 51
france (50) 50
time factors (50) 50
hepatitis b - immunology (49) 49
ribavirin (47) 47
rna (47) 47
rna, viral - blood (47) 47
investigating or analysing materials by determining theirchemical or physical properties (46) 46
measuring (46) 46
mutation (46) 46
physics (46) 46
testing (46) 46
virus replication (46) 46
hepacivirus - immunology (45) 45
specific therapeutic activity of chemical compounds ormedicinal preparations (45) 45
hepatocellular-carcinoma (44) 44
liver cirrhosis (44) 44
alanine transaminase - blood (43) 43
dna, viral - analysis (43) 43
follow-up studies (43) 43
hepatitis b - complications (42) 42
mice (42) 42
virus diseases (42) 42
aids (41) 41
france - epidemiology (41) 41
health aspects (41) 41
hepatitis c - epidemiology (41) 41
ribavirin - therapeutic use (41) 41
virus-infection (41) 41
disease (40) 40
hepatitis b surface antigens - analysis (40) 40
hiv (40) 40
pharmacology & pharmacy (40) 40
amino acid sequence (39) 39
antiviral agents (39) 39
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1317) 1317
French (613) 613
German (18) 18
Portuguese (10) 10
Spanish (6) 6
Danish (2) 2
Chinese (1) 1
Japanese (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Hepatology, ISSN 0270-9139, 07/2011, Volume 54, Issue 1, pp. 60 - 69
Journal Article
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2010, Volume 54, Issue 6, pp. 1114 - 1122
Background & Aims BI201335 is a highly specific and potent HCV protease inhibitor. This multiple rising dose trial evaluated antiviral activity and safety in... 
Gastroenterology and Hepatology | Antiviral | Resistant variants | Hepatitis C virus | Pegylated interferon | Ribavirin | PLUS RIBAVIRIN | BILN-2061 | TELAPREVIR | EFFICACY | VX-950 | HEPATITIS-C-VIRUS | IN-VITRO | EARLY ANTIVIRAL ACTIVITY | PEGINTERFERON ALPHA-2A | ATAZANAVIR | GASTROENTEROLOGY & HEPATOLOGY | Antiviral Agents - pharmacokinetics | Hepatitis C - drug therapy | Protease Inhibitors - pharmacokinetics | Humans | Middle Aged | Hepacivirus - genetics | Male | Thiazoles - administration & dosage | Recombinant Proteins | Oligopeptides - adverse effects | Thiazoles - adverse effects | Thiazoles - pharmacokinetics | Protease Inhibitors - pharmacology | Hepatitis C - blood | Ribavirin - administration & dosage | Protease Inhibitors - administration & dosage | Protease Inhibitors - adverse effects | Adult | Female | Hepacivirus - drug effects | Antiviral Agents - pharmacology | Double-Blind Method | Oligopeptides - pharmacokinetics | Carrier Proteins - antagonists & inhibitors | Viral Nonstructural Proteins - genetics | Antiviral Agents - administration & dosage | Polyethylene Glycols - administration & dosage | Interferon-alpha - administration & dosage | Drug Resistance, Viral - genetics | Hepacivirus - enzymology | Antiviral Agents - adverse effects | Hepatitis C - virology | Oligopeptides - administration & dosage | Thiazoles - pharmacology | Oligopeptides - pharmacology | Viral Load - drug effects | Viral Nonstructural Proteins - antagonists & inhibitors | Medical colleges | Antiviral agents | Care and treatment | Safety and security measures | Hotels and motels | Immunodeficiency | Aspartate | Biological response modifiers | HIV (Viruses) | Anti-HIV agents | Complications and side effects | Protease inhibitors | Proteases | Genetic aspects | Hepatitis C | Viral Nonstructural Proteins | Oligopeptides | Polyethylene Glycols | Interferon-alpha | Protease Inhibitors | Drug Resistance, Viral | Antiviral Agents | Viral Load | Life Sciences | Thiazoles | Hepacivirus | Carrier Proteins | Cancer
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2011, Volume 364, Issue 13, pp. 1195 - 1206
Journal Article
Clinical Gastroenterology and Hepatology, ISSN 1542-3565, 2010, Volume 8, Issue 11, pp. 924 - 933
Journal Article
Journal Article